FDC Ltd (FDC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 248455, "name": "FDC", "stock_name": "FDC", "full_name": "FDC Ltd", "name_url": "stocks-analysis/fdc", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "352.85", "chg": -14.05, "chgp": "-3.83%", "dir": -1, "prev_price": "366.90", "mcapval": "5,882.00 Cr", "mcap": "Small Cap", "scripcode": 531599, "symbol": "FDC", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE258B01022", "curr_date": "Mar 13", "curr_time": "", "bse_nse_vol": "83.99 k", "exc_status": "Active", "traded_date": "Mar 13, 2026", "traded_date_str": "2026 03 13", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fdc-248455-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "FDC Ltd is Rated Strong Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-strong-sell-by-marketsmojo-3877950", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FDCLtd_mojoScore_3877950.png", "date": "2026-03-07 10:10:15", "description": "FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 March 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "FDC Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-falls-to-52-week-low-amidst-continued-downtrend-3864467", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FDCLtd_priceRelatedfactors_3864467.png", "date": "2026-03-02 11:01:21", "description": "FDC Ltd’s share price declined sharply to a fresh 52-week low of Rs.330.05 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have been under pressure for several sessions, reflecting a combination of subdued financial performance and valuation concerns." }, { "title": "FDC Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-falls-to-52-week-low-amidst-continued-downtrend-3860504", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_priceRelatedfactors_3860504.png", "date": "2026-02-27 15:15:22", "description": "FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.355.05 today, marking a significant decline amid a sustained downward trend. The stock has underperformed both its sector and the broader market, reflecting ongoing concerns about its financial performance and valuation metrics." }, { "title": "FDC Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-strong-sell-3852761", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_mojoScore_3852761.png", "date": "2026-02-24 10:10:27", "description": "FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "FDC Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-strong-sell-3834940", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_mojoScore_3834940.png", "date": "2026-02-12 10:10:26", "description": "FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "FDC Ltd Valuation Shifts Signal Deteriorating Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-signal-deteriorating-price-attractiveness-amid-sector-challenges-3827730", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_valuationdot_3827730.png", "date": "2026-02-09 08:00:28", "description": "FDC Ltd’s valuation metrics have recently shifted from fair to expensive territory, prompting a reassessment of its price attractiveness relative to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector. Despite a strong market cap grade, the company’s deteriorating mojo score and downgraded rating to Strong Sell highlight growing investor caution amid subdued returns and stretched multiples." }, { "title": "FDC Ltd Declines 2.29% Amid Valuation Concerns and Weak Q3 Results", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-declines-229-amid-valuation-concerns-and-weak-q3-results-3827387", "imagepath": "", "date": "2026-02-08 11:02:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Valuation shifts to expensive amid mixed market returns</p>\n <p><strong>5 Feb:</strong> Q3 FY26 results reveal profit margin contraction</p>\n <p><strong>6 Feb:</strong> Stock hits 52-week low of Rs.357.45</p>\n <p><strong>6 Feb:</strong> Week closes at Rs.368.70 (-2.29%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.377.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.368.70</div><div class=\"stat-change neg..." }, { "title": "FDC Ltd Stock Falls to 52-Week Low of Rs.357.45 Amidst Weak Financial Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-falls-to-52-week-low-of-rs35745-amidst-weak-financial-performance-3824311", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_priceRelatedfactors_3824311.png", "date": "2026-02-06 11:12:29", "description": "Shares of FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined sharply to hit a new 52-week low of Rs.357.45 on 6 February 2026, marking a significant milestone in the stock’s ongoing downward trajectory." }, { "title": "Are FDC Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-fdc-ltd-latest-results-good-or-bad-3822834", "imagepath": "", "date": "2026-02-05 19:18:40", "description": "FDC Ltd's latest financial results for Q3 FY26 reveal significant operational challenges. The company reported net sales of ₹464.71 crores, reflecting a marginal year-on-year increase of 0.13%, but a sequential decline of 1.76% compared to the previous quarter. This indicates a struggle to maintain revenue levels in a competitive environment. \n\nThe net profit for the quarter was ₹28.30 crores, which represents a year-on-year decrease of 23.60% and a slight sequential decline of 0.25%. This persistent drop in net profit raises concerns about the company's profitability and operational efficiency.\n\nA critical highlight from the results is the operating profit margin, which fell to 11.25% from 22.97% in the same quarter last year, marking a substantial erosion of 11.72 percentage points. This decline suggests that FDC is facing severe margin pressures, likely due to rising costs and competitive pricing strateg..." } ], "total": 219, "sid": "248455", "stock_news_url": "https://www.marketsmojo.com/news/fdc-248455" }, "announcements": [ { "details": "FDC Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "FDC Limited - Clarification - Financial Results", "datetime": "14-Nov-2019" }, { "details": "FDC Limited has informed the Exchange regarding 'Acquisition of Registered Trademark/ Brand \"ENTEROPLUS\" from GlaxoSmithKline Pharmaceuticals Limited (GSK)'.", "source": "NSE", "caption": "FDC Limited - Updates", "datetime": "18-Oct-2019" }, { "details": "FDC Limited has informed the Exchange regarding 'Certificate in terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 ( said regulations ) on behalf of FDC Limited ( the Company ) for the quarter ended on September 30, 2019'.'.", "source": "NSE", "caption": "FDC Limited - Updates", "datetime": "16-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "FDC Ltd has declared <strong>500%</strong> dividend, ex-date: 11 Feb 26", "dt": "2026-02-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Valuation shifts to expensive amid mixed market returns

5 Feb: Q3 FY26 results reveal profit margin contraction

6 Feb: Stock hits 52-week low of Rs.357.45

6 Feb: Week closes at Rs.368.70 (-2.29%)

Read full news article

FDC Ltd Stock Falls to 52-Week Low of Rs.357.45 Amidst Weak Financial Performance

2026-02-06 11:12:29

Shares of FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined sharply to hit a new 52-week low of Rs.357.45 on 6 February 2026, marking a significant milestone in the stock’s ongoing downward trajectory.

Read full news article

Are FDC Ltd latest results good or bad?

2026-02-05 19:18:40

FDC Ltd's latest financial results for Q3 FY26 reveal significant operational challenges. The company reported net sales of ₹464.71 crores, reflecting a marginal year-on-year increase of 0.13%, but a sequential decline of 1.76% compared to the previous quarter. This indicates a struggle to maintain revenue levels in a competitive environment. The net profit for the quarter was ₹28.30 crores, which represents a year-on-year decrease of 23.60% and a slight sequential decline of 0.25%. This persistent drop in net profit raises concerns about the company's profitability and operational efficiency. A critical highlight from the results is the operating profit margin, which fell to 11.25% from 22.97% in the same quarter last year, marking a substantial erosion of 11.72 percentage points. This decline suggests that FDC is facing severe margin pressures, likely due to rising costs and competitive pricing strateg...

Read full news article